KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Current Deferred Revenue (2016 - 2025)

Resmed's Current Deferred Revenue history spans 16 years, with the latest figure at $176.0 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 12.49% year-over-year to $176.0 million; the TTM value through Dec 2025 reached $176.0 million, up 12.49%, while the annual FY2025 figure was $166.0 million, 8.83% up from the prior year.
  • Current Deferred Revenue reached $176.0 million in Q4 2025 per RMD's latest filing, up from $167.8 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $176.0 million in Q4 2025 to a low of $105.3 million in Q1 2021.
  • Average Current Deferred Revenue over 5 years is $138.2 million, with a median of $143.9 million recorded in 2023.
  • Peak YoY movement for Current Deferred Revenue: dropped 3.85% in 2022, then soared 35.61% in 2023.
  • A 5-year view of Current Deferred Revenue shows it stood at $111.6 million in 2021, then increased by 19.94% to $133.9 million in 2022, then grew by 11.19% to $148.9 million in 2023, then rose by 5.11% to $156.5 million in 2024, then grew by 12.49% to $176.0 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Current Deferred Revenue are $176.0 million (Q4 2025), $167.8 million (Q3 2025), and $166.0 million (Q2 2025).